Approvable designations; Nonapprovable designation; Fast-track designations; Priority review; Orphan drug designations
Approvable designations
Nonapprovable designation
Fast-track designations
Orphan drug designations
FDA Issues Complete Response for High-Dose Opioid Rescue Med
July 16th 2024OX124 is a nasal spray provides rapid absorption of naloxone for patients experiencing an opioid overdose. The FDA would like to see additional technical data, as well as data on whether patients can correctly use the device.
Read More